Saturday 17 October 2026
Export NCEL’s income statement to Excel — free account
NewcelX Ltd.
NCEL Healthcare Biotechnology
Insiders bought in the last twelve months.
2.50
0.35
−12.28%
Follow NCEL
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | 0.04 | 0.09 | 0.03 | 2.38 | 2.75 | 0.23 | 0.09 | 0.76 |
Net Debt/EBITDA |
— | (2.05) | (0.02) | (0.63) | 0.46 | 0.58 | (0.06) | (4.28) | 0.74 |
Debt/Assets |
0.00% | 4,871.70% | 43.38% | 123.23% | 0.00% | 0.00% | 88.47% | 855.59% | 3.10% |
Debt/Equity |
— | (0.80) | (0.05) | (0.17) | 0.00 | 0.00 | (0.18) | (0.97) | 0.05 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.53 | 0.03 | 0.25 | 1.25 | 0.84 | 0.80 | 0.15 | 0.33 |
Capex/Depreciation |
— | — | 0.00 | 0.00 | (0.77) | 0.00 | 0.00 | (0.01) | (0.15) |
Interest Coverage |
— | (6.27) | (4,197.00) | (26.49) | (246.58) | (162.63) | (98.47) | (0.41) | (0.43) |
| — | 68.69% | 72.70% | 37.76% | 283.03% | (862.93%) | 438.41% | 85.53% | 2,225.20% | |
| — | (7,069.78%) | (1,293.85%) | (299.94%) | (342.48%) | (219.34%) | (218.86%) | (523.49%) | (134.43%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (29.63%) |
Return on Tangible Assets |
— | 221.41% | 149.10% | 40.84% | (356.69%) | (279.36%) | 199.88% | 90.01% | 904.14% |
Average Days of Receivables |
— | 0.00 | 0.00 | — | — | — | — | — | — |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.71 |
Share Based Compensation of Revenue |
— | — | — | — | — | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | (0.25) | (11.11) | (41.92) | (502.54) | (282.10) | (101.51) | (0.36) | (0.72) |
Cash per Share |
— | 0.00 | 12.88 | 5.39 | 182.26 | 181.88 | 9.41 | 0.22 | 0.57 |
Shareholders Equity per Share |
— | (0.79) | (360.88) | (516.33) | 18.20 | 66.68 | (92.60) | (2.70) | 1.89 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (0.79) | (360.88) | (516.33) | 18.20 | 66.68 | (92.60) | (2.70) | 1.89 |
Free Cash Flow |
— | (2.73) | (0.19) | (0.73) | (14.98) | (13.88) | (9.68) | (1.07) | (2.77) |
Working Capital |
— | (2.32) | (3.65) | (7.01) | 3.32 | 5.89 | (6.10) | (8.12) | (1.01) |
Capital Expenditures |
— | — | — | — | (0.04) | — | — | (0.01) | (0.01) |
Net Current Asset Value |
— | (8.87) | (6.49) | (10.00) | 0.50 | 3.25 | (8.86) | (8.12) | (1.01) |
| Other line items | |||||||||
Quick Ratio |
— | 0.01 | 0.05 | 0.01 | 2.26 | 2.66 | 0.11 | 0.07 | 0.52 |
Depreciation/Fixed assets |
— | — | 0.00 | 0.00 | 1.75 | 4.33 | 1.70 | 3.36 | 0.58 |
Cash ROIC |
— | 159.46% | 3.36% | 9.86% | (250.70%) | (113.49%) | 153.67% | (282.11%) | (28.29%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | — | — | — | — | — | — |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | 0.00 | 0.00 | — | — | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (0.25) | (11.11) | (41.92) | (501.21) | (282.10) | (101.51) | (0.36) | (0.72) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | (1.33) | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 0.04 | 0.04 | — | — | — | — | — | — |
Average Payables |
— | 1.82 | 1.82 | 3.26 | 2.87 | 2.06 | 3.50 | 2.90 | 1.67 |
Average Assets |
— | 0.07 | 0.42 | 0.95 | 3.49 | 7.52 | 5.56 | 1.37 | 6.17 |
Average Common Equity |
— | (7.49) | (7.49) | (7.58) | (4.22) | 1.91 | (2.78) | (8.41) | (0.37) |
Capex to Sales |
— | — | — | — | 0.00 | — | — | 0.00 | 0.00 |
Columns are period end dates